This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Bcn Peptides S.a.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Marc Gómez Caminals
Introduction
Marc Gómez Caminals is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide formulations. With a total of 2 patents to his name, his work focuses on addressing ocular diseases and related conditions.
Latest Patents
One of his latest patents is a topical ophthalmic peptide formulation. This innovative formulation is designed for the treatment and/or local prevention of ocular diseases, with a particular emphasis on posterior segment eye diseases. Another significant patent involves peptide ligands of somatostatin receptors. This patent covers peptide derivatives, their stereoisomers, and pharmaceutically acceptable salts, along with methods of obtaining them and their use in treating conditions where somatostatin receptors are expressed.
Career Highlights
Marc Gómez Caminals is associated with Bcn Peptides S.A., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various ocular conditions significantly.
Collaborations
He collaborates with talented individuals such as Berta Ponsati Obiols and Jimena Fernández Carneado, contributing to a dynamic research environment.
Conclusion
Marc Gómez Caminals exemplifies innovation in the pharmaceutical industry through his groundbreaking patents and collaborative efforts. His contributions are paving the way for advancements in the treatment of ocular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile